Clinical Trials for BioSyn

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: BioSyn

Clinical Trials (6)

NCT06645301
BGT007 Treatment for Recurrent/refractory Gastrointestinal Malignancies
EARLY_PHASE1Not yet recruiting
15 participants
Started: Nov 30, 2024 · Completed: Aug 31, 2027
2 conditions2 sponsors0 locations
NCT06645314
Study on the Safety and Efficacy of BST06 Injection in the Treatment of Advanced Hepatocellular Carcinoma
EARLY_PHASE1Not yet recruiting
16 participants
Started: Nov 30, 2024 · Completed: Aug 31, 2027
1 condition2 sponsors0 locations
NCT06643910
A Study on the Safety and Efficacy of BST08 in Treating Advanced Non-Small Cell Lung Cancer
NANot yet recruiting
12 participants
Started: Oct 24, 2024 · Completed: Aug 31, 2027
1 condition2 sponsors1 location
NCT06526832
A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer
PHASE1Recruiting
9 participants
Started: Jul 4, 2024 · Completed: Dec 3, 2025
1 condition1 sponsor1 location
NCT06173726
Investigator-initiated Phase I Exploratory Clinical Study of the Safety, Tolerability, and Efficacy of BST02 Injection in the Treatment of Locally Advanced/Metastatic Liver Cancer
EARLY_PHASE1Not yet recruiting
6 participants
Started: Dec 5, 2023 · Completed: Dec 5, 2026
1 condition2 sponsors1 location
NCT06152757
BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors
EARLY_PHASE1Recruiting
14 participants
Started: Oct 9, 2023 · Completed: Jul 19, 2027
1 condition2 sponsors1 location